Why the study?
Does posterior tilting of the EV-ICD lead affect device performance and safety?
Does posterior tilting of the EV-ICD lead affect device performance and safety?
Posterior tilting of the extravascular ICD lead can occur shortly after implantation but appears to be a benign phenomenon that does not compromise device electrical performance or necessitate surgical correction.
The extravascular implantable cardioverter-defibrillator (EV-ICD), a novel nontransvenous alternative to conventional ICD systems, was recently validated for its safety and efficacy in terminating ventricular arrhythmias.1,2 The high-voltage lead is placed substernally, allowing relatively low pacing and defibrillation thresholds. Consequently, the EV-ICD offers antitachycardia pacing and short-term pause-prevention pacing alongside defibrillation capabilities.
No takes yet. Share an insight, caveat, or question.
Karvonen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: